Compounds > 2-3-5-4--tetrahydroxystilbene-2-o-glucopyranoside

2-3-5-4--tetrahydroxystilbene-2-o-glucopyranoside and Asthma

2-3-5-4--tetrahydroxystilbene-2-o-glucopyranoside has been researched along with Asthma* in 1 studies

Other Studies

1 other study(ies) available for 2-3-5-4--tetrahydroxystilbene-2-o-glucopyranoside and Asthma

ArticleYear
The Protective Effects of 2,3,5,4'-Tetrahydroxystilbene-2-
    International journal of molecular sciences, 2018, Dec-12, Volume: 19, Issue:12

    Asthma is an inflammatory disease caused by an imbalance of Th1 and Th2 cells. In general, asthma is characterized by a stronger Th2 response. Most conventional asthma treatment focuses on improving airway flow or suppression of airway inflammation. To reduce the side effects of currently used asthma medicines, we have conducted studies on natural products that have no side effects. 2,3,5,4'-tetrahydroxystilbene-2-O-β-d-glucoside (TSG), the main compound of

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Disease Models, Animal; Female; Glucosides; Immunoglobulin Class Switching; Inflammation; Inflammation Mediators; Lung; Mice, Inbred C57BL; Ovalbumin; Protective Agents; Respiratory Hypersensitivity; Stilbenes; Th1 Cells; Th2 Cells

2018